|
97
|
307
|
5jgaA |
Crystal structure of human tak1/tab1 fusion protein in complex with ligand 11c |
|
88
|
306
|
5jgdA |
Crystal structure of human tak1/tab1 fusion protein in complex with ligand 12 |
|
75
|
288
|
5kbrA |
Pak1 in complex with 7-azaindole inhibitor |
|
83
|
299
|
5k4jA |
Crystal structure of cdk2 in complex with compound 22 |
|
82
|
277
|
5jsmA |
Brafv600e kinase domain in complex with chemically linked vemurafenib inhibitor vem-3-vem |
|
75
|
298
|
5jkgA |
The crystal structure of fgfr4 kinase domain in complex with ly2874455 |
|
84
|
305
|
5jfvA |
Crystal structure of trka in complex with pf-05206283 |
|
88
|
323
|
5j9yA |
Egfr-t790m in complex with pyrazolopyrimidine inhibitor 1b |
|
90
|
433
|
5kcvA |
Crystal structure of allosteric inhibitor, arq 092, in complex with autoinhibited form of akt1 |
|
116
|
350
|
5k4iA |
Crystal structure of erk2 in complex with compound 22 |
|
93
|
309
|
5j7hA |
Crystal structure of anaplastic lymphoma kinase (alk) bound by brigatinib |
|
106
|
297
|
5iqhA |
Aminoglycoside phosphotransferase (2'')-ia (ctd of aac(6')-ie/aph(2'')-ia) s214a mutant in complex with gmppnp and magnesium |
|
78
|
276
|
5j5sA |
Src kinase in complex with a sulfonamide inhibitor |
|
100
|
338
|
5izfA |
Complex of pka with the bisubstrate protein kinase inhibitor arc-1408 |
|
107
|
300
|
5iqdA |
Aminoglycoside phosphotransferase (2'')-ia (ctd of aac(6')-ie/aph(2'')-ia) in complex with gmppnp, magnesium, and ribostamycin |
|
99
|
312
|
5iuhA |
Crystal structure of the anaplastic lymphoma kinase (alk) in complex with 5d |
|
97
|
292
|
5ih6A |
Human casein kinase 1 isoform delta (kinase domain) in complex with epiblastin a derivative |
|
108
|
297
|
5iqeA |
Aminoglycoside phosphotransferase (2'')-ia (ctd of aac(6')-ie/aph(2'')-ia) in complex with gmppnp, magnesium, and neomycin b |
|
78
|
273
|
5ipjA |
Crystal structure of human pim-1 kinase in complex with a quinazolinone-pyrrolopyrrolone inhibitor. |
|
85
|
317
|
5iu2A |
Discovery of imidazoquinolines as a novel class of potent, selective and in vivo efficacious cot kinase inhibitors |
|
104
|
297
|
5iqgA |
Aminoglycoside phosphotransferase (2'')-ia (ctd of aac(6')-ie/aph(2'')-ia) in complex with gdp, magnesium, and gentamicin c1 |
|
78
|
271
|
5itaA |
Crystal structure of braf kinase domain bound to az-vem |
|
104
|
301
|
5iqcA |
Aminoglycoside phosphotransferase (2'')-ia (ctd of aac(6')-ie/aph(2'')-ia) in complex with gmppnp, magnesium, and gentamicin c1 |
|
101
|
312
|
5iugA |
Crystal structure of anaplastic lymphoma kinase (alk) in complex with 5a |
|
107
|
298
|
5iqfA |
Aminoglycoside phosphotransferase (2'')-ia (ctd of aph(6')-ie/aph(2'')-ia) in complex with gdp and magnesium |
|
91
|
300
|
5ig1A |
Crystal structure of s. rosetta camkii kinase domain |
|
93
|
293
|
5ih5A |
Human casein kinase 1 isoform delta (kinase domain) in complex with epiblastin a |
|
79
|
298
|
5ievA |
Crystal structure of bay 1000394 (roniciclib) bound to cdk2 |
|
82
|
296
|
5imeA |
Crystal structure of p21-activated kinase 1 (pak1) in complex with compound 9 |
|
96
|
293
|
5ih4A |
Human casein kinase 1 isoform delta apo (kinase domain) |
|
81
|
274
|
5iisA |
Design, synthesis and structure activity relationship of potent pan-pim kinase inhibitors derived from the pyridyl-amide scaffold |
|
84
|
298
|
5if1A |
Crystal structure apo cdk2/cyclin a |
|
84
|
292
|
5imxA |
Anaplastic lymphoma kinase (alk) catalytic domain complexed with novel inhibitor 3-sulfonylpyrazol-4-amino pyrimidine |
|
82
|
298
|
5ieyA |
Crystal structure of a cdk inhibitor bound to cdk2 |
|
81
|
284
|
5ia1A |
Crystal structure of ephrin a2 (epha2) receptor protein kinase with mln8054 |
|
82
|
286
|
5ia0A |
Crystal structure of ephrin a2 (epha2) receptor protein kinase with alisertib (mln8237) |
|
85
|
298
|
5iexA |
Crystal structure of (r,s)-s-{4-[(5-bromo-4-{[(2r,3r)-2-hydroxy-1-methylpropyl]oxy}- pyrimidin-2-yl)amino]phenyl}-s-cyclopropylsulfoximide bound to cdk2 |
|
102
|
363
|
5idnA |
Cdk8-cycc in complex with [(s)-2-(4-chloro-phenyl)-pyrrolidin-1-yl]-(3-methyl-1h-pyrazolo[3,4-b]pyridin-5-yl)-methanone |
|
87
|
292
|
5i9vA |
Crystal structure of ephrin a2 (epha2) receptor protein kinase with ags |
|
91
|
291
|
5ia2A |
Crystal structure of ephrin a2 (epha2) receptor protein kinase with compound 66 |
|
99
|
360
|
5idpA |
Cdk8-cycc in complex with (3-amino-1h-indazol-5-yl)-[(s)-2-(4-fluoro-phenyl)-piperidin-1-yl]-methanone |
|
82
|
293
|
5i9zA |
Crystal structure of ephrin a2 (epha2) receptor protein kinase with danusertib (pha739358) |
|
83
|
291
|
5i9wA |
Crystal structure of ephrin a2 (epha2) receptor protein kinase with anp |
|
104
|
362
|
5icpA |
Cdk8-cycc in complex with [(s)-2-(4-chloro-phenyl)-pyrrolidin-1-yl]-(5-methyl-imidazo[5,1-b][1,3,4]thiadiazol-2-yl)-methanone |
|
104
|
365
|
5i5zA |
Cdk8-cycc in complex with 8-(1-methyl-2,2-dioxo-2,3-dihydro-1h-2l6-benzo[c]isothiazol-5-yl)-[1,6]naphthyridine-2-carboxylic acid methylamide |
|
80
|
295
|
5ia3A |
Crystal structure of ephrin a2 (epha2) receptor protein kinase with pd173955 |
|
83
|
273
|
5ia4A |
Crystal structure of ephrin a2 (epha2) receptor protein kinase with foretinib (xl880) |
|
91
|
293
|
5i9xA |
Crystal structure of ephrin a2 (epha2) receptor protein kinase with bosutinib (ski-606) |
|
90
|
297
|
5i9yA |
Crystal structure of ephrin a2 (epha2) receptor protein kinase with dasatinib |
|
79
|
289
|
5i0bA |
Structure of pak4 |
